主页 文献库文献详情
PMID: 25447091 已发表 · ppublish ger

[The risk-reducing mastectomy: unnecessary hysteria or life-saving prophylaxis?].

Therapeutische Umschau. Revue therapeutique ·第 71 卷 ·第 12 期 ·2015-02-06

Olariu Radu, Shafighi Maziar, Constantinescu Mihai A

摘要

The prophylactic (risk-reducing) mastectomy is a world-wide recognized method for specifically treating the increased breast cancer risk in patients showing a BRCA1 and/or BRCA2 mutation as well as other patient groups at increased breast cancer risk. This option should be offered to all patients having the pertinent risk profile. Breast reconstruction is an integral part of the risk-reducing mastectomy procedure and all possible methods of breast reconstruction, especially autologous tissue reconstruction should be offered to all patients having a medical indication and desiring this surgical treatment. These patients are best managed in certified Breast Care Centres where the different medical and surgical specialists can address interdisciplinary all aspects of genetic counselling, preoperative counselling, mastectomy and reconstructive techniques as well as the necessary postoperative surveillance.

文献信息
期刊
Therapeutische Umschau. Revue therapeutique
期刊简称
Ther Umsch
发表日期
2015-02-06
收录日期
2014-12-02
更新日期
2014-12-02
语言
ger
国家/地区
Switzerland
NLM ID
0407224
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com